One of the greatest contributions to public health is vaccination. The majority of affluent nations have high rates of childhood vaccination, indicating that vaccination is still largely regarded as a public health policy in these nations. But there might be many individuals who are under-vaccinated. The rise of VPD outbreaks, such as measles, poliomyelitis, and pertussis, and under- or non-vaccinated communities have been linked in several nations. The World Health Organization (WHO) has identified vaccine hesitancy as one of the top 10 health hazards for 2019. Recently, there have been reports of vaccine reluctance in Saudi Arabia. Currently, the need for awareness campaigns about the benefits of vaccination is needed more than ever. In this review we will be looking at immunization hesitancy in Saudi Arabia, its definition, factors, and possible solutions.
Saudi Medical Horizons Journal · مجلد 2 (3) · 103-112
Background All elements of everyday life have been seriously and significantly impacted by the global COVID-19 outbreak. Previous research has demonstrated a connection between infectious disease epidemics and sleep disturbances as well as psychological discomfort, such as traumatic stress, melancholy, and anxiety. ObjectivesThe study aimed to summarize current evidences about sleep quality and sleep disorders for patients that had Covid-19 infection MethodsFor article selection, the PubMed database and EBSCO Information Services were used. All articles relevant with our topic and other articles were used in our review. Other articles that were not related to this field were excluded. The data was extracted in a specific format that was reviewed by the group members. Conclusion Our study included 8 studies in total. Patients with recovered COVID-19 showed a statistically significant prevalence of insomnia than control groups. Patients must be advised to follow-up if they have trouble sleeping as a result. Early detection and treatment of people who are experiencing insomnia are crucial to prevent long-term harmful effects as increase in the intensity of depression, anxiety, and post-traumatic stress that were shown to be substantially correlated with poor sleep quality.
Papain-like protease is an essential enzyme in the proteolytic processing required for the replication of SARS-CoV-2. Accordingly, such an enzyme is an important target for the development of anti-SARS-CoV-2 agents which may reduce the mortality associated with outbreaks of SARS-CoV-2. A set of 69 semi-synthesized molecules that exhibited the structural features of SARS-CoV-2 papain-like protease inhibitors (PLPI) were docked against the coronavirus papain-like protease (PLpro) enzyme (PDB ID: (4OW0). Docking studies showed that derivatives 34 and 58 were better than the co-crystallized ligand while derivatives 17, 28, 31, 40, 41, 43, 47, 54, and 65 exhibited good binding modes and binding free energies. The pharmacokinetic profiling study was conducted according to the four principles of the Lipinski rules and excluded derivative 31. Furthermore, ADMET and toxicity studies showed that derivatives 28, 34, and 47 have the potential to be drugs and have been demonstrated as safe when assessed via seven toxicity models. Finally, comparing the molecular orbital energies and the molecular electrostatic potential maps of 28, 34, and 47 against the co-crystallized ligand in a DFT study indicated that 28 is the most promising candidate to interact with the target receptor (PLpro).
The SARS-CoV-2 outbreak is the COVID-19 disease, which has caused massive health devastation, prompting the World Health Organization to declare a worldwide health emergency. The corona virus infected millions of people worldwide, and many died as a result of a lack of particular medications. The current emergency necessitates extensive therapy in order to stop the spread of the coronavirus. There are various vaccinations available, but no validated COVID-19 treatments. Since its outbreak, many therapeutics have been tested, including the use of repurposed medications, nucleoside inhibitors, protease inhibitors, broad spectrum antivirals, convalescence plasma therapies, immune-modulators, and monoclonal antibodies. However, these approaches have not yielded any outcomes and are mostly used to alleviate symptoms associated with potentially fatal adverse drug reactions. Nanoparticles, on the other hand, may prove to be an effective treatment for COVID-19. They can be designed to boost the efficacy of currently available antiviral medications or to trigger a rapid immune response against COVID-19. In the last decade, there has been significant progress in nanotechnology. This review focuses on the virus's basic structure, pathogenesis, and current treatment options for COVID-19. This study addresses nanotechnology and its applications in diagnosis, prevention, treatment, and targeted vaccine delivery, laying the groundwork for a successful pandemic fight.
SARS-CoV-2COVID-19 pandemicnanotechnologynanoparticle drug delivery
The World Health Organization (WHO) announced COVID-19, a novel coronavirus outbreak, as a pandemic in 2020. In the month of February 2020, the disease began to spread through the Middle East. The first case of COVID-19 in the Kingdom of Saudi Arabia was identified in March 2020, and it is now one of the region's most affected countries. Analyzing the disease's propagation pattern may aid in the development of pandemic-fighting strategies. This study aims to analyze the trend of COVID-19's spread, its recovery, and mortality in the Kingdom of Saudi Arabia (KSA). Two to three major cities from the 13 provinces of the country were chosen, and the rate of infection recovery was recorded from the first month until the number of confirmed cases showed a decline. The data published on the official Ministry of Health website were recorded on an Excel sheet, graphically represented as figures to indicate the pattern of spread. According to the study's findings, COVID-19 positive cases were discovered in the majority of provinces as early as March 2020. The province of Makkah had the largest number of COVID-19 positive cases (30.7%), followed by Riyadh (23%). The province of Al Jowf had the lowest number of COVID-19 cases (0.3%). Tabuk province had the highest rate of recovery (97.8%), followed by the Northern Border Province (96.7%). Makkah province had the highest mortality rate (2.6%), followed by Al Jawf province (2.4%). The peak case-fatality ratio was recorded in August and September. The highest number of tests to detect the COVID-19 was performed in the month of July, and the highest percentage of positive cases was detected in June (19.55%). All the provinces from the month of September 2020 showed a progressive decline in the number of confirmed COVID-19 cases. According to this study, COVID-19 infection was found in the majority of Saudi Arabian provinces in March 2020, with a peak in June-July 2020. Considering the climatic and demographic characteristics of the region, specific modalities need to be adopted in collaboration with international guidelines to defeat the COVID-19 pandemic.
Background A recent outbreak of COVID-19 which was initially reported in Wuhan City, China, has become a worldwide pandemic. This global public health threat drew the attention of the medical and scientific community to make the necessary research efforts to combat the spread of the virus. Predictors of preventive behaviors could be of considerable importance relevant to identifying high-risk groups to manage their behavior. We aimed to investigate the association between people's perception of COVID-19 adherence to preventive measures, susceptibility, seriousness, benefits, motivators, barriers, confidence, and information sources. Methods We conducted a cross-sectional study during the early phase of the COVID-19 pandemic, enrolling 1,568 participants from WhatsApp groups, aged 16 years and above from March to April 2020 in Saudi Arabia. We prepared an online Arabic self-administered questionnaire, which consisted of (1) sociodemographic characteristics; (2) compliance to preventive measures, including the perception of susceptibility, seriousness, benefits, motivation, barriers to preventive measures, self-confidence; and (3) sources of COVID-19 information. Results Of the 1,568 participants, 60% (n = 1,004) were women, 54.1% (n = 459) were unmarried, and 80.2% (n = 1,258) had earned university degrees. Regarding compliance and perception toward preventive measures, 64% of participants washed hands with soap and water; 50% followed the cough etiquette; 17.5% avoided touching their eyes, nose, and mouth; and 34.6% never shook hands with others. Approximately 52.2%-69.7% avoided going to crowded places and wore facial masks as needed. In addition, 24.3% of people observed social distancing. However, 52.4% did not receive the annual flu vaccine. Approximately 83% used banknotes, 69.8% made online payments, and 51.8% avoided ATM/credit card use. The perception of susceptibility and the seriousness of COVID-19 infection accounted for 8.5% and 50% of participants, respectively. Perceived benefits and motivation reached more than 90%. Barriers for not being able to practice preventive measures were the fear of nasal swabs, forgetfulness, and negligence, which rated 39% and 66%, respectively. Confidence in practicing the preventive measures and distinguishing the symptoms of COVID-19 accounted for 80% and 60% of the participants, respectively. The most used sources to retrieve information were the Ministry of Health (MOH) news and reports and social media, representing 53.5% and 24.6%, respectively. Conclusions During the early phase of the pandemic, people's perception of susceptibility was low, which resulted in a lack of awareness of some citizens to take the COVID-19 infection seriously. Thus, the benefits of preventive measures did not fully translate into practice. The current successful decline of COVID-19 cases should be accompanied by continuing health promotion and disease prevention programs utilizing all avenues and opportunities to remind people of scientific, religious, and cultural practices of handwashing, coughing etiquette. The persistent use of personal protective equipment (PPE), such as facial masks, gloves, and, for frontline workers, shields and protective garments is necessary. Family physicians and teams should play a vital role in this battle.
BioMed Research International · مجلد 2021 (1) · 9195965-9195965
Since its outbreak, the coronavirus (COVID-19) pandemic has caused havoc on people's lives. All activities were paused due to the virus's spread across the continents. Researchers have been working hard to find new medication treatments for the COVID-19 pandemic. The World Health Organization (WHO) recommends that safety and self-measures play a major role in preventing the virus from spreading from one person to another. Wireless technology is playing a critical role in avoiding viral propagation. This technology mainly comprises of portable devices that assist self-isolated patients in adhering to safe precautionary measures. Government officials are currently using wireless technologies to identify infected people at large gatherings. In this research, we gave an overview of wireless technologies that assisted the general public and healthcare professionals in maintaining effective healthcare services during COVID-19. We also discussed the possible challenges faced by them for effective implementation in day-to-day life. In conclusion, wireless technologies are one of the best techniques in today's age to effectively combat the pandemic.
COVID-19 pandemicwireless technologyhealth careinfection control
Saudi Journal of Biological Sciences · مجلد 28 (9) · 4926-4930
BACKGROUND & OBJECTIVES: In late December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS COV-2) occurred in the city of Wuhan, the capital of the Hubei province in the central part of the People's Republic of China (Ren et al., 2020). In Saudi Arabia, the first case of COVID-19 was reported in March 2, 2020. In March 8, 2020, the Saudi authorities adopted the lockdown strategy to contain the disease. The aim of this study was to determine the effectiveness of the various phases of the lockdown strategy in Saudi Arabia and its impact on the basic reproductive number (R0) of the COVID-19 outbreak. MATERIAL AND METHODS: (2020) was used to estimate the changes in community mobility during the various phases of the lockdown. The basic reproductive number (R0) of the COVID-19 outbreak was calculated daily using the Susceptible, Infected and Recovered (SIR) model based on the Saudi Ministry of Health (MOH) daily reports. This is a standard system to determine the spread of the virus on the basis of infection rate, quarantine rate as well as confirmation rate. The mean values of the calculated R0 during each interval were compared using one-way ANOVA test. RESULTS: There was no statistically significant difference between the mean values of the different phases of the lockdown (P > 0.05). Moreover, mean R0 value of the second interval was 0.09 higher than the initial interval with free community mobility. Furthermore, the mean R0 values of the third interval with the full lockdown was 0.28 higher than the initial interval. CONCLUSION: Early implementation of lockdown strategy combined with other social distancing strategies help in containing infectious outbreaks in their early phases. Continuous assessment of such strategies' effectiveness provides decision makers with precious information needed to justify their application when considering their economic impact.
Pakistan Journal of Medical and Health Sciences · مجلد 15 (10) · 2838-2840
Background: Over the past decade, excessive use of Colistin against multidrug-resistant, Gram-negative bacteria have resulted in the evolution of resistance to Colistin. Objective: To evaluate efficacy of Colistin against multidrug-resistant organisms (MDRO), the emergence of Colistin resistance and its effects on clinical outcomes. Study Design: Retrospective study Place and Duration of Study: King Saud Medical City (KSMC) from 1st October 2015 till 31st January 2016. Methodology: Forty-three patients, resistant to Colistin on blood culture and sensitivity were enrolled. Results: Colistin was not effective at breaking the MDRO. The results revealed no significant impact of Colistin on site of infection such as chest, urinary tract or skin (p=0.612), types of organisms (p=0.629), length of hospital stay and the IV Colistin days (p=0.097 and p=0.166 respectively) in the past 12 months. The positive finding was that more than two third (76.7%) of the ICU patients were alive. Conclusion: Emergence of Multi drug resistance organism is matter of global concern that caused the ineffectiveness of many potent antibiotics and led to the drastic clinical outcomes. Collaboration between medical, paramedical, and administrative staff, with strict implementation of preventive protocol can slow down the velocity of microbial multidrug resistance. Keywords: Multi-drug resistant, Colistin, Outbreak, Intensive care unit, critically ill patients
International Journal of Pharmaceutical Sciences and Research · مجلد 12 (2)
The outbreak of a novel coronavirus 2019 was traced back in China in late 2019, followed by their worldwide transmission as a pandemic. From January to August 2020, a total of 1,724 papers were published, where 125 were only published in August 2020, demonstrating the importance and need for current awareness and research to overcome […]
Journal of Family Medicine and Primary Care · مجلد 9 (9) · 4521-4525
An unknown pneumonia outbreak has been reported by hospitals in Wuhan, China, in late December 2019. A public health emergency of international concern announced by the World Health Organization (WHO) on the January 31, 2020. The virus named by the WHO as coronavirus disease 2019 (COVID-19). The cases reached (266,073 cases) and deaths (11,184 deaths) globally by the end of March 21, 2020, and considered as a pandemic. By a systemic review, articles and case reports revealed 74 pregnant women for the possibility of vertical transmission of the virus from COVID-19-infected mother to infant. Review also showed that there is no difference between pregnant and nonpregnant regarding clinical manifestations. Concerning the vertical transmission, none of the positive mothers had a positive infant with COVID-19 except 1 case report that showed the infant had positive COVID-19 by the throat swab, yet negative cord blood, placenta, and mother's breast milk.